Testing effectiveness (Phase 2)Ended earlyNCT03152552
What this trial is testing
A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Who this might be right for
Diabetes Mellitus and Heart Failure
Novartis Pharmaceuticals 125